Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations.
Open Access
- 1 February 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (S1), 17S-22S
- https://doi.org/10.1111/j.1365-2125.1983.tb02102.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- Familial Bleeding Tendency with Partial Platelet Thromboxane Synthetase Deficiency: Reorientation of Cyclic Endoperoxide MetabolismBritish Journal of Haematology, 1981
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- EVIDENCE FOR DISTINCT PROSTAGLANDIN-I2 AND PROSTAGLANDIN-D2 RECEPTORS IN HUMAN-PLATELETS1979
- Evidence that Calcium Regulates Platelet FunctionThrombosis and Haemostasis, 1978
- Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977